Myogenin and Desmin Immunohistochemistry in the Assessment of Post-Chemotherapy Genitourinary Embryonal Rhabdomyosarcoma: Prognostic and Management Implications

Journal of Urology

Volumn 176, Issue 4 SUPPL., 2006, Pages 1751-1754

  Godbole, P ^a   Outram, A ^a   Wilcox, D T ^a   Duffy, P G ^a   Sebire, N J ^a  

^a Department of Paediatric Urology ^*  (United Kingdom)

Author keywords

biopsy; desmin; myogenin; rhabdomyosarcoma; urogenital system

Indexed keywords

DESMIN; MYOGENIN;

ARTICLE; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; MYOBLAST; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BIOPSY; UROGENITAL TRACT CANCER; UROLOGIC SURGERY; VAGINA CARCINOMA;

CHILD; CHILD, PRESCHOOL; DESMIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MYOGENIN; PROSTATIC NEOPLASMS; RHABDOMYOSARCOMA, EMBRYONAL; URINARY BLADDER NEOPLASMS; UROGENITAL NEOPLASMS; VAGINAL NEOPLASMS;

EID: 33748676638     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.03.117     Document Type: Article

References (11)

1. Lee H., Farhat W., Prasad A., Alabdul-Aaly M., and Merguerian P. Pediatric genitourinary tumours. Curr Opin Oncol 11 (1999) 218
2. Wexler L.H., and Helman L.J. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and Practice of Pediatric Oncology. 3rd ed. (1997), Lippincott-Raven, Philadelphia 799-829
3. Pappo A.S., and Shapiro D.N. Rhabdomyosarcoma. biology and therapy. Cancer Treat Res 92 (1997) 309
4. Coffin C.M., Rulon J., Smith L., Bruggers C., and White F.V. Pathologic features of rhabdomyosarcoma before and after treatment. a clinicopathologic and immunohistochemical analysis. Mod Pathol 10 (1997) 1175
5. Sebire N.J., and Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 56 (2003) 412
6. Dias P., Kumar P., Marsden H.B., Morris-Jones P.H., Birch J., Swindell R., et al. Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas. Br J Cancer 56 (1987) 361
7. Cessna M., Coffin C., Perkins S., Tripp S., Layfield L., Daines C., et al. Myogenin (MYOG) and MyoD1 (MD1) expression in rhabdomyosarcoma (RMS) and spindle cell mimics. a study of 135 cases. Lab Invest 81 (2001) 36
8. Cessna M.H., Zhou H., Perkins S.L., Tripp S.R., Layfield L., Daines C., et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 25 (2001) 1150
9. Kumar S., Perlman E., Harris C.A., Raffeld M., and Tsokos M. Myogenin is a specific marker for rhabdomyosarcoma. an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 13 (2000) 988
10. Cui S., Hano H., Harada T., Takai S., Masui F., and Ushigome S. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol Int 49 (1999) 62
11. Folpe A.L. MyoD1 and myogenin expression in human neoplasia. a review and update. Adv Anat Pathol 9 (2002) 198